|Podcasts|December 1, 2021
Navigating New State Drug Price Transparency Laws
Author(s)Model N
As the State Drug Pricing Transparency Program expands, what does that mean for manufacturers? Jesse Mendelsohn, Vice President, Centers of Excellence for Model N, the leader in cloud revenue management solutions for life science companies, discusses challenges for manufacturers as the State Price Transparency Program expands how they should plan for this change and the solutions they will need.
Advertisement
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
FDA Approves Novo Nordisk’s Wegovy Pill, Marking First Oral GLP-1 for Weight Management
2
Yusen Logistics Completes Walden Health Acquisition, Expanding European Healthcare Logistics Platform
3
Pharma Pulse: FDA Clears First Oral Wegovy; Yusen Logistics Seals European Health Deal
4
Leveraging Global Scale and Collaboration for Pharma Supply Chain Innovation
5